Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ACCUSTEM SCIENCES, INC. (ACUT) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ACCUSTEM SCIENCES, INC. (ACUT), most recent 12 months reported: net loss $1.65M. Latest balance sheet on file: liquid cash $12.93K, total debt $62.64K, net cash -$49.71K. From SEC filings. Others in Pharmaceutical Preparations: ABVC BioPharma, Inc. · Adicet Bio, Inc. · Acrivon Therapeutics, Inc. · ACTUATE THERAPEUTICS, INC. · Acurx Pharmaceuticals, Inc. · ADIAL PHARMACEUTICALS, INC. · AEON Biopharma, Inc. · Akari Therapeutics, Plc

Stock screener

Watchlist